Upregulation of IL-6 in plasma levels of mice has been shown to promote tumor growth, angiogenesis, metastasis, and the expansion of cancer stem cells, as well contribute to multidrug resistance via gp130/MAPK/STAT3-mediated activation of C/EBPβ/δ transcription factors [109,122]. This evidence concerns the gene STAT3 and neoplasm.